Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Brian Skorney's Stock Ratings
Baird Analyst
Brian Skorney is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
9.86%
Smart Score
Overall Average Return Percentile
57th
Number of Ratings
165
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | 37.29% | $80 → $88 | Maintains | Outperform | Get Alert | |
| 11/13/2025 | ANRO | Buy Now | Alto Neuroscience | $18.00 | 22.22% | $16 → $22 | Maintains | Outperform | Get Alert | |
| 11/04/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | -30.03% | $21 → $15 | Maintains | Neutral | Get Alert | |
| 10/20/2025 | ANRO | Buy Now | Alto Neuroscience | $18.00 | -11.11% | $10 → $16 | Maintains | Outperform | Get Alert | |
| 09/26/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | 25.71% | $58 → $62 | Maintains | Outperform | Get Alert | |
| 08/12/2025 | BHVN | Buy Now | Biohaven | $11.10 | 368.47% | $57 → $52 | Maintains | Outperform | Get Alert | |
| 07/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 63.26% | $30 → $35 | Maintains | Outperform | Get Alert | |
| 07/11/2025 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 142.24% | $105 → $121 | Maintains | Outperform | Get Alert | |
| 06/18/2025 | DYN | Buy Now | Dyne Therapeutics | $19.59 | 63.35% | $46 → $32 | Maintains | Outperform | Get Alert | |
| 06/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 39.94% | $60 → $30 | Maintains | Outperform | Get Alert | |
| 05/08/2025 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 110.21% | $102 → $105 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 179.87% | $193 → $60 | Maintains | Outperform | Get Alert | |
| 05/02/2025 | BIIB | Buy Now | Biogen | $175.74 | 45.1% | $300 → $255 | Maintains | Outperform | Get Alert | |
| 04/30/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | -22.01% | $652 → $587 | Maintains | Neutral | Get Alert | |
| 04/28/2025 | BHVN | Buy Now | Biohaven | $11.10 | 413.51% | $60 → $57 | Maintains | Outperform | Get Alert | |
| 04/25/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | -13.37% | $759 → $652 | Maintains | Neutral | Get Alert | |
| 03/27/2025 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 104.2% | $72 → $102 | Maintains | Outperform | Get Alert | |
| 02/27/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -14.2% | $50 → $55 | Maintains | Outperform | Get Alert | |
| 02/12/2025 | GILD | Buy Now | Gilead Sciences | $120.14 | -16.76% | $95 → $100 | Maintains | Neutral | Get Alert | |
| 02/05/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 0.85% | $940 → $759 | Maintains | Neutral | Get Alert | |
| 12/13/2024 | DYN | Buy Now | Dyne Therapeutics | $19.59 | 134.81% | → $46 | Initiates | → Outperform | Get Alert | |
| 12/13/2024 | BNTC | Buy Now | Benitec Biopharma | $11.98 | 150.42% | → $30 | Initiates | → Outperform | Get Alert | |
| 12/02/2024 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 44.14% | $72 → $72 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/29/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 4324.78% | $14 → $5 | Maintains | Outperform | Get Alert | |
| 11/26/2024 | ENTA | Buy Now | Enanta Pharma | $14.87 | 34.5% | $26 → $20 | Maintains | Outperform | Get Alert | |
| 11/15/2024 | BIIB | Buy Now | Biogen | $175.74 | 70.71% | $294 → $300 | Maintains | Outperform | Get Alert | |
| 11/13/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -22% | $44 → $50 | Maintains | Outperform | Get Alert | |
| 11/07/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 800.25% | $200 → $193 | Maintains | Outperform | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $120.14 | -20.93% | $80 → $95 | Maintains | Neutral | Get Alert | |
| 10/31/2024 | ALMS | Buy Now | Alumis | $11.53 | 116.83% | → $25 | Initiates | → Outperform | Get Alert | |
| 10/23/2024 | ANRO | Buy Now | Alto Neuroscience | $18.00 | -44.44% | $32 → $10 | Maintains | Outperform | Get Alert | |
| 09/25/2024 | AMGN | Buy Now | Amgen | $324.50 | -33.74% | $215 → $215 | Reiterates | Underperform → Underperform | Get Alert | |
| 09/23/2024 | BHVN | Buy Now | Biohaven | $11.10 | 440.54% | $58 → $60 | Maintains | Outperform | Get Alert | |
| 08/08/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -31.36% | $39 → $44 | Maintains | Outperform | Get Alert | |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | 16.13% | $157 → $180 | Maintains | Outperform | Get Alert | |
| 07/29/2024 | BIIB | Buy Now | Biogen | $175.74 | 67.29% | $316 → $294 | Maintains | Outperform | Get Alert | |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 832.9% | $170 → $200 | Maintains | Outperform | Get Alert | |
| 06/20/2024 | GILD | Buy Now | Gilead Sciences | $120.14 | -33.41% | $80 → $80 | Maintains | Neutral | Get Alert | |
| 06/17/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -39.16% | $34 → $39 | Maintains | Outperform | Get Alert | |
| 06/13/2024 | LXEO | Buy Now | Lexeo Therapeutics | $9.90 | 182.83% | → $28 | Initiates | → Outperform | Get Alert | |
| 05/23/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | 25.71% | $52 → $62 | Maintains | Outperform | Get Alert | |
| 05/10/2024 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 44.14% | → $72 | Initiates | → Outperform | Get Alert | |
| 04/16/2024 | MRNS | Buy Now | Marinus Pharma | — | — | $20 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/06/2024 | RGNX | Buy Now | Regenxbio | $13.83 | 182% | $34 → $39 | Maintains | Outperform | Get Alert | |
| 02/29/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | 5.43% | $45 → $52 | Maintains | Outperform | Get Alert | |
| 02/27/2024 | ANRO | Buy Now | Alto Neuroscience | $18.00 | 77.78% | → $32 | Initiates | → Outperform | Get Alert | |
| 02/14/2024 | BIIB | Buy Now | Biogen | $175.74 | 79.81% | $333 → $316 | Maintains | Outperform | Get Alert | |
| 12/14/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | $28 → $3 | Downgrade | Outperform → Neutral | Get Alert | |
| 12/08/2023 | BHVN | Buy Now | Biohaven | $11.10 | 422.52% | → $58 | Initiates | → Outperform | Get Alert | |
| 12/08/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $43.60 | 44.5% | → $63 | Initiates | → Outperform | Get Alert | |
| 09/11/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | -8.76% | $43 → $45 | Maintains | Outperform | Get Alert | |
| 08/11/2023 | MRNS | Buy Now | Marinus Pharma | — | — | $24 → $20 | Maintains | Outperform | Get Alert | |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -4.52% | $140 → $148 | Maintains | Outperform | Get Alert | |
| 07/31/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $85 → $173 | Maintains | Outperform | Get Alert | |
| 06/30/2023 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $3 → $5 | Maintains | Outperform | Get Alert | |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 0.98% | $800 → $760 | Maintains | Neutral | Get Alert | |
| 06/20/2023 | RGNX | Buy Now | Regenxbio | $13.83 | 203.69% | → $42 | Initiates | → Outperform | Get Alert | |
| 06/07/2023 | BIIB | Buy Now | Biogen | $175.74 | 93.47% | → $340 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/02/2023 | RGNX | Buy Now | Regenxbio | $13.83 | 203.69% | → $42 | Initiates | → Outperform | Get Alert | |
| 05/22/2023 | ICPT | Buy Now | Intercept Pharma | — | — | $35 → $18 | Maintains | Outperform | Get Alert | |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -28.89% | $280 → $325 | Maintains | Neutral | Get Alert | |
| 04/25/2023 | APLT | Buy Now | Applied Therapeutics | $0.11 | 12289.38% | $18 → $14 | Maintains | Outperform | Get Alert | |
| 03/30/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $49.32 | -2.68% | → $48 | Initiates | → Outperform | Get Alert | |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 6.3% | $756 → $800 | Maintains | Neutral | Get Alert | |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 842.23% | $152 → $202 | Maintains | Outperform | Get Alert | |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $40 → $85 | Maintains | Neutral | Get Alert | |
| 02/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | 0.45% | $670 → $756 | Maintains | Neutral | Get Alert | |
| 11/09/2022 | MRNS | Buy Now | Marinus Pharma | — | — | $32 → $24 | Maintains | Outperform | Get Alert | |
| 10/31/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -38.74% | → $280 | Maintains | Neutral | Get Alert | |
| 10/24/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $20 → $27 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/12/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $43 → $55 | Maintains | Outperform | Get Alert | |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | $52 → $35 | Maintains | Outperform | Get Alert | |
| 09/28/2022 | BIIB | Buy Now | Biogen | $175.74 | 93.47% | $224 → $340 | Upgrade | Neutral → Outperform | Get Alert | |
| 08/16/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $66 → $40 | Maintains | Outperform | Get Alert | |
| 08/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $37 → $27 | Maintains | Neutral | Get Alert | |
| 08/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -45.3% | $250 → $250 | Maintains | Neutral | Get Alert | |
| 07/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -45.3% | → $250 | Maintains | Neutral | Get Alert | |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $14.87 | 505.25% | $130 → $90 | Maintains | Outperform | Get Alert | |
| 05/17/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $72 → $66 | Maintains | Outperform | Get Alert | |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/23/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $240 → $240 | Maintains | Outperform | Get Alert | |
| 01/30/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $240 → $240 | Maintains | Outperform | Get Alert | |
| 01/27/2022 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | → $28 | Initiates | → Outperform | Get Alert | |
| 12/21/2021 | BIIB | Buy Now | Biogen | $175.74 | 46.81% | $296 → $258 | Maintains | Neutral | Get Alert | |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $110 → $37 | Downgrade | Outperform → Neutral | Get Alert | |
| 12/02/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $240 → $240 | Maintains | Outperform | Get Alert | |
| 10/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $240 → $240 | Maintains | Outperform | Get Alert | |
| 08/03/2021 | IMVT | Buy Now | Immunovant | $26.00 | -61.54% | → $10 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/01/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $240 → $240 | Maintains | Outperform | Get Alert | |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -47.49% | $252 → $240 | Maintains | Outperform | Get Alert | |
| 06/08/2021 | BIIB | Buy Now | Biogen | $175.74 | 117.37% | $216 → $382 | Upgrade | Underperform → Neutral | Get Alert | |
| 05/20/2021 | VTGN | Buy Now | VistaGen Therapeutics | $4.42 | 103.62% | → $9 | Initiates | → Outperform | Get Alert | |
| 04/20/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -44.86% | $252 → $252 | Maintains | Outperform | Get Alert | |
| 02/26/2021 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 40.19% | $18 → $6 | Downgrade | Outperform → Neutral | Get Alert | |
| 02/23/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -44.86% | $220 → $252 | Upgrade | Neutral → Outperform | Get Alert | |
| 11/10/2020 | ICPT | Buy Now | Intercept Pharma | — | — | → $52 | Upgrade | Neutral → Outperform | Get Alert | |
| 08/18/2020 | PRNB | Buy Now | Principia Biopharma | — | — | $78 → $100 | Maintains | Outperform | Get Alert | |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | → $52 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/25/2020 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -53.2% | → $30 | Initiates | → Outperform | Get Alert | |
| 06/25/2020 | ALBO | Buy Now | Albireo Pharma | — | — | → $52 | Initiates | → Outperform | Get Alert | |
| 06/19/2020 | BIIB | Buy Now | Biogen | $175.74 | 29.74% | $290 → $228 | Maintains | Underperform | Get Alert | |
| 05/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | -32.24% | $487 → $510 | Maintains | Neutral | Get Alert | |
| 04/24/2020 | PRNB | Buy Now | Principia Biopharma | — | — | $64 → $78 | Maintains | Outperform | Get Alert | |
| 03/31/2020 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $283 → $268 | Maintains | Outperform | Get Alert | |
| 03/17/2020 | ENTA | Buy Now | Enanta Pharma | $14.87 | 303.5% | → $60 | Upgrade | Neutral → Outperform | Get Alert | |
| 02/26/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 02/06/2020 | BIIB | Buy Now | Biogen | $175.74 | 65.02% | $250 → $290 | Maintains | Underperform | Get Alert | |
| 01/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -49.68% | $210 → $230 | Downgrade | Outperform → Neutral | Get Alert | |
| 01/31/2020 | AMGN | Buy Now | Amgen | $324.50 | -42.99% | $173 → $185 | Downgrade | Neutral → Underperform | Get Alert | |
| 01/08/2020 | APLT | Buy Now | Applied Therapeutics | $0.11 | 37953.1% | $24 → $43 | Maintains | Outperform | Get Alert | |
| 01/08/2020 | IMVT | Buy Now | Immunovant | $26.00 | — | — | Initiates | → Outperform | Get Alert | |
| 12/20/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 795.59% | $181 → $192 | Maintains | Outperform | Get Alert | |
| 12/02/2019 | BIIB | Buy Now | Biogen | $175.74 | 42.26% | → $250 | Downgrade | Neutral → Underperform | Get Alert | |
| 11/01/2019 | CELG | Buy Now | Celgene | — | — | → $101 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/20/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 744.28% | $202 → $181 | Maintains | Outperform | Get Alert | |
| 08/07/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 06/10/2019 | APLT | Buy Now | Applied Therapeutics | $0.11 | 21138.94% | → $24 | Initiates | → Outperform | Get Alert | |
| 01/04/2019 | CELG | Buy Now | Celgene | — | — | → $92 | Upgrade | Neutral → Outperform | Get Alert | |
| 08/03/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 07/30/2018 | AMGN | Buy Now | Amgen | $324.50 | -44.84% | $165 → $179 | Maintains | Neutral | Get Alert | |
| 07/25/2018 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -21.29% | $100 → $122 | Maintains | Outperform | Get Alert | |
| 07/25/2018 | BIIB | Buy Now | Biogen | $175.74 | 98.02% | $323 → $348 | Maintains | Neutral | Get Alert | |
| 07/24/2018 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $47 → $92 | Maintains | Outperform | Get Alert | |
| 07/10/2018 | BIIB | Buy Now | Biogen | $175.74 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 06/21/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 842.23% | $120 → $202 | Maintains | Outperform | Get Alert | |
| 05/24/2018 | MRNS | Buy Now | Marinus Pharma | — | — | → $15 | Initiates | → Outperform | Get Alert | |
| 05/07/2018 | CRIS | Buy Now | Curis | $1.21 | 148.43% | $6 → $3 | Maintains | Outperform | Get Alert | |
| 05/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $155.00 | -35.48% | $84 → $100 | Maintains | Outperform | Get Alert | |
| 04/25/2018 | BIIB | Buy Now | Biogen | $175.74 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 02/09/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 01/30/2018 | ABLX | Buy Now | Ablynx | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/20/2017 | ABLX | Buy Now | Ablynx NV - American Depositary Shares | — | — | → $33 | Initiates | → Outperform | Get Alert | |
| 11/14/2017 | BGNE | Buy Now | BeiGene | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/03/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 11/01/2017 | CEMP | Buy Now | Cempra | — | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 08/10/2017 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 08/08/2017 | ENTA | Buy Now | Enanta Pharma | $14.87 | 142.1% | $27 → $36 | Maintains | Neutral | Get Alert | |
| 08/01/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 01/25/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | → $43 | Initiates | → Outperform | Get Alert | |
| 01/24/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | → $43 | Initiates | → Outperform | Get Alert | |
| 11/29/2016 | NVLS | Buy Now | Nivalis Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/28/2016 | DFT | Buy Now | Dupont Fabros Technology | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 11/22/2016 | ENTA | Buy Now | Enanta Pharma | $14.87 | 81.57% | $22 → $27 | Maintains | Neutral | Get Alert | |
| 11/08/2016 | SHNY | Buy Now | Direxion Funds ETF | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 11/02/2016 | CEMP | Buy Now | Cempra, Inc. - Common Stock | — | — | — | Downgrade | Outperform → Underperform | Get Alert | |
| 11/02/2016 | SYRG | Buy Now | Synergy Resources Corporation Common Stock | — | — | — | Initiates | → Outperform | Get Alert | |
| 08/05/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/11/2016 | BIIB | Buy Now | Biogen | $175.74 | 52.5% | $292 → $268 | Maintains | Neutral | Get Alert | |
| 02/29/2016 | BGNE | Buy Now | BeiGene | — | — | → $44 | Initiates | → Outperform | Get Alert | |
| 02/26/2016 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 07/27/2015 | BIIB | Buy Now | Biogen | $175.74 | 79.81% | $480 → $316 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/08/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $752.62 | -30.78% | $490 → $521 | Maintains | Outperform | Get Alert | |
| 06/01/2015 | CRIS | Buy Now | Curis | $1.21 | 479.66% | $5 → $7 | Maintains | Outperform | Get Alert | |
| 05/06/2015 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 03/18/2015 | ICPT | Buy Now | Intercept Pharma | — | — | $258 → $344 | Maintains | Outperform | Get Alert | |
| 12/23/2014 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | $12 → $16 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/28/2014 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | -2.05% | $53 → $21 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/22/2014 | BIIB | Buy Now | Biogen | $175.74 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 06/24/2014 | ENTA | Buy Now | Enanta Pharma | $14.87 | 175.72% | → $41 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/11/2014 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | $4 → $12 | Upgrade | Neutral → Outperform | Get Alert | |
| 10/02/2013 | CRIS | Buy Now | Curis | $1.21 | 479.66% | → $7 | Initiates | → Outperform | Get Alert | |
| 04/03/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 193.86% | → $63 | Initiates | → Outperform | Get Alert | |
| 01/03/2013 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | → $17 | Initiates | → Outperform | Get Alert | |
| 09/12/2012 | AMGN | Buy Now | Amgen | $324.50 | -74.11% | $83 → $84 | Downgrade | Outperform → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved